These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20879822)

  • 1. Ten years single institutional experience of treatment for advanced laryngeal cancer in Kyoto University.
    Kada S; Hirano S; Tateya I; Kitamura M; Ishikawa S; Kanda T; Asato R; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):68-73. PubMed ID: 20879822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supraglottic laryngeal cancer: analysis of treatment results.
    Sessions DG; Lenox J; Spector GJ
    Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of outcome for advanced-stage supraglottic laryngeal cancer.
    Ganly I; Patel SG; Matsuo J; Singh B; Kraus DH; Boyle J; Wong RJ; Lee N; Pfister DG; Shaha AR; Shah JP
    Head Neck; 2009 Nov; 31(11):1489-95. PubMed ID: 19408292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, risk factors, and overall survival rate of laryngeal cancer in Songklanagarind Hospital.
    Dechaphunkul T
    J Med Assoc Thai; 2011 Mar; 94(3):355-60. PubMed ID: 21560844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
    Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
    Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
    Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
    Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years single institutional experience of treatment for advanced hypopharyngeal cancer in Kyoto University.
    Hirano S; Tateya I; Kitamura M; Kada S; Ishikawa S; Kanda T; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):56-61. PubMed ID: 20879820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment and results of N1 supraglottic laryngeal carcinoma].
    Tong K; Tu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(5):307-9. PubMed ID: 9642369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of curative effects on laryngeal carcinoma patients in the northeast region of China.
    Ji W; Guan C; Pan Z
    Acta Otolaryngol; 2008 May; 128(5):574-7. PubMed ID: 18421614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histological clinical features of the primary tumor as prognostic factors in patients with laryngeal carcinoma].
    Starska K; Kulig A; Łukomski M
    Pol Merkur Lekarski; 2003 Jul; 15(85):55-60. PubMed ID: 14593961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and pitfalls of stage I/II glottic cancer.
    Tateya I; Hirano S; Kitamura M; Kada S; Ishikawa S; Kanda T; Asato R; Tanaka S; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):62-7. PubMed ID: 20879821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson Cancer Center experience with combined therapy.
    Lee NK; Goepfert H; Wendt CD
    Laryngoscope; 1990 Aug; 100(8):831-6. PubMed ID: 2381259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years single institutional experience of treatment for oral cancer in Kyoto University.
    Kitamura M; Hirano S; Tateya I; Kada S; Ishikawa S; Kanda T; Asato R; Ito J
    Acta Otolaryngol Suppl; 2010 Nov; (563):74-8. PubMed ID: 20879823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results.
    Spector JG; Sessions DG; Emami B; Simpson J; Haughey B; Harvey J; Fredrickson JM
    Laryngoscope; 1995 Apr; 105(4 Pt 1):397-406. PubMed ID: 7715386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stomal recurrence post laryngectomy in University College Hospital, Ibadan.
    Onakoya PA; Nwaorgu OG; Kokong DD; Adeosun AA; Ayodele KJ
    Afr J Med Med Sci; 2004 Mar; 33(1):65-8. PubMed ID: 15490797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.